Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gynecologic 2Head & Neck 1

Conditions

Uterine Cervical Neoplasms 10Neoplasms 9Breast Neoplasms 9Colorectal Neoplasms 8Lung Neoplasms 5Papillomavirus Infections 3Uterine Cervical Dysplasia 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Heart Diseases 2HIV Infections 2Gastrointestinal Neoplasms 2Esophageal Neoplasms 2End Stage Liver Disease 2the Rate of Participation in Screening for PBC 1Warts 1Venous Thromboembolism 1Uterine Cervical Diseases 1Urinary Bladder Neoplasms 1Tinea 1Squamous Intraepithelial Lesions 1Squamous Cell Carcinoma of Head and Neck 1Smoking 1Skin Neoplasms 1Retinoblastoma 1Radiation Injuries 1Pulmonary Atelectasis 1Postural Orthostatic Tachycardia Syndrome 1Postoperative Complications 1

Interventions

human papillomavirus vaccine, L1 type 16, 18 40Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 32Papillomavirus Vaccines 24Human Papillomavirus Recombinant Vaccine nonavalent 12Vaccines 11Blood Specimen Collection 10Data Collection 9Colposcopy 9Human Papillomavirus DNA Tests 8Specimen Handling 7Radiotherapy, Intensity-Modulated 7Cisplatin 7Surveys and Questionnaires 6Educational Status 6Early Intervention, Educational 6Carboplatin 6Vaginal Smears 5Vaccines, Synthetic 5Methods 5Engerix-B 4fludarabine 3epigallocatechin gallate 3artesunic acid 3artemisinin 3Watchful Waiting 3Polymerase Chain Reaction 3Patient Navigation 3Paclitaxel 3Observation 3Mass Screening 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Papillomavirus Infections × Mass Screening × Clear all
NCT07225530 2026-02-25

(iSTAR)

Columbia University

Phase NA Recruiting
600 enrolled
Gynecologic

Uterine Cervical Neoplasms, HIV Infections, Papillomavirus Infections

NCT04965792 2025-06-17

Post-treatment Surveillance in HPV+ Oropharyngeal SCC

Dana-Farber Cancer Institute

Active not recruiting
150 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Papillomavirus Infections

NCT02460237 2018-02-08

HPV Self-Test Intervention in Ohio Appalachia

Ohio State University Comprehensive Cancer Center

Phase NA Completed
103 enrolled
Gynecologic

Uterine Cervical Neoplasms, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡